References
- 1. MOZAFFARIAN D, BENJAMIN EJ, GO AS, ARNETT DK, BLAHA MJ, CUSHMAN M, et al. Heart disease and stroke statistics – 2016 update: a report from the American Heart Association. Circulation 2016;133(4):e38-360.
- 2. HANSSON GK. Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine 2005;352(16):1685-95.
- 3. GUASTI L, DENTALI F, CASTIGLIONI L, MARONI L, MARINO F, SQUIZZATO A, et al. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. Thrombosis and haemostasis 2011;106(04):591-9.
- 4. HORNE BD, ANDERSON JL, JOHN JM, WEAVER A, BAIR TL, JENSEN KR, et al. Which white blood cell subtypes predict increased cardiovascular risk? Journal of the American College of Cardiology 2005;45(10):1638-43.
- 5. THOMSON SP, GIBBONS RJ, SMARS PA, SUMAN VJ, PIERRE RV, SANTRACH PJ, et al. Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Annals of internal medicine 1995;122(5):335-41.
- 6. ARRUDA-OLSON AM, REEDER GS, BELL MR, WESTON SA, ROGER VL. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circulation: Cardiovascular Quality and Outcomes 2009;2(6):656-62.
- 7. O'DONOGHUE M, MORROW DA, CANNON CP, GUO W, MURPHY SA, GIBSON CM, et al. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. European heart journal 2008;29(8):984-91.
- 8. AKPEK M, KAYA MG, LAM YY, SAHIN O, ELCIK D, CELIK T, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. The American journal of cardiology 2012;110(5):621-7.
- 9. KAYA MG, AKPEK M, LAM YY, YARLIOGLUES M, CELIK T, GUNEBAKMAZ O, et al. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. International journal of cardiology 2013;168(2):1154-9.
- 10. SOYLU K, YUKSEL S, GULEL O, ERBAY AR, MERIC M, ZENGIN H, et al. The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention. Journal of thoracic disease 2013;5(3):258.
- 11. GHAFFARI S, NADIRI M, POURAFKARI L, SEPEHRVAND N, MOVASAGPOOR A, RAHMATVAND N, et al. The predictive value of total neutrophil count and neutrophil/lymphocyte ratio in predicting in-hospital mortality and complications after STEMI. Journal of cardiovascular and thoracic research 2014;6(1):35.
- 12. ALEXANDRAKIS MG, PASSAM FH, MOSCHANDREA IA, CHRISTOPHORIDOU AV, PAPPA CA, COULOCHERI SA, et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. American journal of clinical oncology 2003;26(2):135-40.
- 13. GARY T, PICHLER M, BELAJ K, HAFNER F, GERGER A, FROEHLICH H, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One 2013;8(7):e67688.
- 14. KRENN-PILKO S, LANGSENLEHNER U, THURNER E, STOJAKOVIC T, PICHLER M, GERGER A, et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. British journal of cancer 2014;110(10):2524.
- 15. AKKAYA E, GUL M, UGUR M. Platelet to lymphocyte ratio: a simple and valuable prognostic marker for acute coronary syndrome. International journal of cardiology 2014;177(2):597-8.
- 16. DE LEMOS JA, BRAUNWALD E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. Journal of the American College of Cardiology 2001;38(5):1283-94.
- 17. SCHRODER R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 2004;110(21):e506-e10.
- 18. PIÉRARD L. ST elevation after myocardial infarction: what does it mean? : BMJ Publishing Group Ltd; 2007.
- 19. CUTLIP DE, WINDECKER S, MEHRAN R, BOAM A, COHEN DJ, VAN ES G-A, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115(17):2344-51.
- 20. PARK JJ, JANG H-J, OH I-Y, YOON C-H, SUH J-W, CHO Y-S, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. The American journal of cardiology 2013;111(5):636-42.
- 21. SHIN H-C, JANG J-S, JIN H-Y, SEO J-S, YANG T-H, KIM D-K, et al. Combined use of neutrophil to lymphocyte ratio and C-reactive protein level to predict clinical outcomes in acute myocardial infarction patients undergoing percutaneous coronary intervention. Korean circulation journal 2017;47(3):383-91.
- 22. SMIT JJJ, OTTERVANGER JP, SLINGERLAND RJ, KOLKMAN JE, SURYAPRANATA H, HOORNTJE JC, et al. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction. The American journal of cardiology 2008;101(4):446-51.